Aarvik Therapeutics
Operator of a proprietary modular platform intended to develop site-specific antibody-drug conjugation technology. The company tool is being used to generate a pipeline of proprietary multi-functional...
Valuation
$0
Share Price
N/A
Total Raised
$11.5M
Last Round
N/A